B&D White Capital Company, LLC Bristol Myers Squibb CO Transaction History

B&D White Capital Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $4.77 Million - $5.69 Million	-98,400 Reduced 95.41%	4,730 $242,000
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $275,266 - $307,791	4,755 Added 4.83%	103,130 $5.99 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $6.27 Million - $6.96 Million	98,375 New	98,375 $6.29 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $11,868 - $13,347	-200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $11,548 - $13,086	200 New	200 $12,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of B&D White Capital Company, LLC, based on Form 13F filings with the SEC.

Stay updated on B&D White Capital Company, LLC with notifications on news.